抗肿瘤坏死因子的研究进展英国生物技术公司（ＢｒｉｔｉｓｈＢｉｏｔｅｃｈ）和葛兰素公司报道了一种与基质金属蛋白酶类（ｍｍＰ）抑制剂抗类作用有关的新作用机制，《Ｎａｔｕｒｅ》杂志中有两篇论文报道，这些抑制剂除抑制相连组织的基质破坏外，还有抑制α－肿瘤坏死... Progress in anti-tumor necrosis factor British Biotech and GSK have reported a new mechanism of action related to the anti-class action of matrix metalloproteinase (mmP) inhibitors. Two in Nature Paper reported that these inhibitors in addition to inhibiting the destruction of the matrix connected to the organization, but also inhibit α-tumor necrosis ...